Joel D. Allen
Cited by
Cited by
Site-specific glycan analysis of the SARS-CoV-2 spike
Y Watanabe, JD Allen, D Wrapp, JS McLellan, M Crispin
Science 369 (6501), 330-333, 2020
Quantitative mass imaging of single biological macromolecules
G Young, N Hundt, D Cole, A Fineberg, J Andrecka, A Tyler, A Olerinyova, ...
Science 360 (6387), 423-427, 2018
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
A Shields, SE Faustini, M Perez-Toledo, S Jossi, E Aldera, JD Allen, ...
Thorax 75 (12), 1089-1094, 2020
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
Y Watanabe, ZT Berndsen, J Raghwani, GE Seabright, JD Allen, ...
Nature communications 11 (1), 1-10, 2020
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
T Tokatlian, BJ Read, CA Jones, DW Kulp, S Menis, JYH Chang, ...
Science 363 (6427), 649-654, 2019
Site-specific glycosylation of virion-derived HIV-1 Env is mimicked by a soluble trimeric immunogen
WB Struwe, E Chertova, JD Allen, GE Seabright, Y Watanabe, DJ Harvey, ...
Cell reports 24 (8), 1958-1966. e5, 2018
Structure of the Lassa virus glycan shield provides a model for immunological resistance
Y Watanabe, J Raghwani, JD Allen, GE Seabright, S Li, F Moser, ...
Proceedings of the National Academy of Sciences 115 (28), 7320-7325, 2018
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
PJM Brouwer, A Antanasijevic, Z Berndsen, A Yasmeen, B Fiala, TPL Bijl, ...
Nature communications 10 (1), 1-17, 2019
HIV-1 vaccine design through minimizing envelope metastability
L He, S Kumar, JD Allen, D Huang, X Lin, CJ Mann, KL Saye-Francisco, ...
Science advances 4 (11), eaau6769, 2018
Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome
medRXIV, 2020
Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva
SE Faustini, SE Jossi, M Perez‐Toledo, AM Shields, JD Allen, ...
Immunology, 2021
Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics
A Torrents de la Pe˝a, K Rantalainen, CA Cottrell, JD Allen, MJ van Gils, ...
PLoS pathogens 15 (7), e1007920, 2019
Rational design of DNA-expressed stabilized native-like HIV-1 envelope trimers
Y Aldon, PF McKay, J Allen, G Ozorowski, RF LÚvai, M Tolazzi, P Rogers, ...
Cell reports 24 (12), 3324-3338. e5, 2018
Signature of antibody domain exchange by native mass spectrometry and collision-induced unfolding
Y Watanabe, S Vasiljevic, JD Allen, GE Seabright, HME Duyvesteyn, ...
Analytical chemistry 90 (12), 7325-7331, 2018
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
PJM Brouwer, M Brinkkemper, P Maisonnasse, N Dereuddre-Bosquet, ...
Cell 184 (5), 1188-1200. e19, 2021
Collision cross sections and ion mobility separation of fragment ions from complex N-glycans
DJ Harvey, Y Watanabe, JD Allen, P Rudd, K Pagel, M Crispin, ...
Journal of The American Society for Mass Spectrometry 29 (6), 1250-1261, 2018
Early Release-Sensitive Detection of SARS-CoV-2–Specific Antibodies in Dried Blood Spot Samples
GL Morley, S Taylor, S Jossi, M Perez-Toledo, SE Faustini, ...
Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors
PA Blundell, NPL Le, J Allen, Y Watanabe, RJ Pleass
Journal of Biological Chemistry 292 (31), 12994-13007, 2017
Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens
A Antanasijevic, G Ueda, PJM Brouwer, J Copps, D Huang, JD Allen, ...
PLoS pathogens 16 (8), e1008665, 2020
Networks of HIV-1 envelope glycans maintain antibody epitopes in the face of glycan additions and deletions
GE Seabright, CA Cottrell, MJ van Gils, A D'addabbo, DJ Harvey, ...
Structure 28 (8), 897-909. e6, 2020
The system can't perform the operation now. Try again later.
Articles 1–20